Skip to main content
Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
10.12
-0.42 (-3.98%)
Oct 24, 2024, 4:00 PM EDT - Market closed

Certara Revenue

Certara had revenue of $93.31M in the quarter ending June 30, 2024, with 3.17% growth. This brings the company's revenue in the last twelve months to $363.55M, up 3.26% year-over-year. In the year 2023, Certara had annual revenue of $354.34M with 5.57% growth.

Revenue (ttm)
$363.55M
Revenue Growth
+3.26%
P/S Ratio
4.63
Revenue / Employee
$261,361
Employees
1,391
Market Cap
1.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.34M18.69M5.57%
Dec 31, 2022335.64M49.54M17.32%
Dec 31, 2021286.10M42.57M17.48%
Dec 31, 2020243.53M35.02M16.79%
Dec 31, 2019208.51M44.79M27.36%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
10x Genomics 631.73M
NovoCure 549.96M
Beam Therapeutics 352.57M
MannKind 248.37M
Arvinas 93.30M
Ocular Therapeutix 61.10M
Nurix Therapeutics 56.42M
Bicycle Therapeutics 39.57M
Revenue Rankings

CERT News

More News